Skip to main content

ATS/Margaret W. Leigh/PCD Foundation Early Career Investigator Award

In order to assure the future of rare disease research, training the next generation of early-stage investigators is key. Our consortium offers both fellowship and grant funding opportunities.

Applicants may request up to $60,000 for one year. Funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Indirect costs will not be paid to the sponsoring institution.

You will be required to pass an eligibility quiz to gain access to the application. 

Note that if you have already submitted an LOI, you do not need to complete a second eligibility quiz. Review eligibility criteria.

ATS Research Program staff will review your application. If there are any problems or if guidelines have not been followed, your proposal will be un-submitted. We cannot accept changes to LOIs or applications once they have been submitted.

Partner grants have unique applications links. Visit the partner grant page to access the application. You will be required to pass an eligibility quiz to gain access to the application

Unrestricted and diversity grant applications are by invitation only following LOI submission. Applicants will be notified of their LOI status in early November 2024, at which point they will gain access to the full application. 

The Research Program uses Foundant Technologies for its LOI and applications. 

Administrative Review 

Research Program staff will review your application. If there are any problems or if guidelines have not been followed, your proposal will be un-submitted. We cannot accept changes to LOIs or applications once they have been submitted. 

ATS uses Foundant Technologies for its online LOI and application. 

  • Please add @grantinterface.com to your address book or contacts to ensure you receive communications regarding your LOI and application. 

Scientific Grant Review 

The ATS Scientific Grant Review Committee (SGRC) is composed of nationally renowned pulmonary, sleep, and critical care researchers. The SGRC leads a rigorous, NIH-style review process to identify the most impactful research proposals. 

Reviewers determine the overall impact of each application by assessing the quality of the investigator’s scientific background and research environment and evaluating each proposal’s overall significance, innovation, feasibility, and importance to patients. 

Grant Review Process 

For its unrestricted and diversity grants, the Research Program employs a two-stage process. Partner grants do not require a letter of intent and are reviewed at the full application stage. 

1. Letter of Intent Stage 

  • Two members of the SGRC review each LOI and provide an overall score. 
  • Researchers submitting LOIs with the highest scores are invited to submit full applications. 
    • Invitations to submit full applications will be made in late October. 

2. Full Application Stage 

  • Full applications are reviewed by three SGRC members, who provide an overall impact score and comments. 
  • Applications are ranked by their average preliminary score. The lowest scoring applications are triaged and not discussed at the review. 
  • The remaining applications are discussed at the SGRC review meeting. The entire committee scores the applications. 
  • The applications are then ranked from lowest to highest average score. The SGRC recommends the top scoring application(s) in each grant category for funding